Literature DB >> 28101995

Cholinergic signaling in myelination.

R Douglas Fields1, Dipankar J Dutta1,2, Jillian Belgrad1, Maya Robnett1.   

Abstract

There is a long history of research on acetylcholine (ACh) function in myelinating glia, but a resurgence of interest recently as a result of the therapeutic potential of manipulating ACh signaling to promote remyelination, and the broader interest in neurotransmitter signaling in activity-dependent myelination. Myelinating glia express all the major types of muscarinic and nicotinic ACh receptors at different stages of development, and acetylcholinesterase and butyrylcholinesterase are highly expressed in white matter. This review traces the history of research on ACh signaling in Schwann cells, oligodendrocytes, and in the myelin sheath, and summarizes current knowledge on the intracellular signaling and functional consequences of ACh signaling in myelinating glia. Implications of ACh in diseases, such as Alzheimer's disease, multiple sclerosis, and white matter toxicity caused by pesticides are considered, together with an outline of major questions for future research. GLIA 2017;65:687-698. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  acetylcholine (ACh); acetylcholinesterase (AChE); butyrylcholinesterase (BChE); muscarinic receptors; nicotinic receptors; organophosphates

Mesh:

Substances:

Year:  2017        PMID: 28101995     DOI: 10.1002/glia.23101

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  21 in total

Review 1.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

Review 2.  Function and Mechanism of Myelin Regulation in Alcohol Abuse and Alcoholism.

Authors:  James Rice; Chen Gu
Journal:  Bioessays       Date:  2019-05-16       Impact factor: 4.345

Review 3.  Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.

Authors:  Donald E Moss; Ruth G Perez
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

Review 4.  Neuron-oligodendroglia interactions: Activity-dependent regulation of cellular signaling.

Authors:  Michael A Thornton; Ethan G Hughes
Journal:  Neurosci Lett       Date:  2020-03-16       Impact factor: 3.046

5.  Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis.

Authors:  Carolina Gabri Nicoletti; Doriana Landi; Fabrizia Monteleone; Giorgia Mataluni; Maria Albanese; Benedetta Lauretti; Camilla Rocchi; Ilaria Simonelli; Laura Boffa; Fabio Buttari; Nicola Biagio Mercuri; Diego Centonze; Girolama Alessandra Marfia
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

Review 6.  Development of the Ontogenetic Self-Regulation Clock.

Authors:  Sari Goldstein Ferber; Aron Weller; Michal Ben-Shachar; Gil Klinger; Ronny Geva
Journal:  Int J Mol Sci       Date:  2022-01-17       Impact factor: 5.923

Review 7.  Schwann cell interactions during the development of the peripheral nervous system.

Authors:  Emma R Wilson; Gustavo Della-Flora Nunes; Michael R Weaver; Luciana R Frick; M Laura Feltri
Journal:  Dev Neurobiol       Date:  2020-05-05       Impact factor: 3.102

8.  Cholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts.

Authors:  Marcelo L Berthier; Irene De-Torres; José Paredes-Pacheco; Núria Roé-Vellvé; Karl Thurnhofer-Hemsi; María J Torres-Prioris; Francisco Alfaro; Ignacio Moreno-Torres; Diana López-Barroso; Guadalupe Dávila
Journal:  Front Hum Neurosci       Date:  2017-06-14       Impact factor: 3.169

Review 9.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

Review 10.  Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?

Authors:  Donald E Moss
Journal:  Int J Mol Sci       Date:  2020-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.